109 related articles for article (PubMed ID: 38488257)
1. FGFR2 and miR-889-3p expression in oral cancer is associated with cervical lymph node metastasis.
Mehdikhani F; Atashbasteh M; Azadi M; Allameh A
Oral Dis; 2024 Mar; ():. PubMed ID: 38488257
[TBL] [Abstract][Full Text] [Related]
2. Possible Role of miR-375-3p in Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma.
Saika M; Nakashiro KI; Tokuzen N; Shirai H; Uchida D
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672573
[TBL] [Abstract][Full Text] [Related]
3. miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.
Yang X; Ruan H; Hu X; Cao A; Song L
Am J Cancer Res; 2017; 7(4):913-922. PubMed ID: 28469963
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion.
Sun Y; Cheng Y; Zhang Y; Han K
Exp Ther Med; 2019 Aug; 18(2):1440-1448. PubMed ID: 31316631
[TBL] [Abstract][Full Text] [Related]
5. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis.
Yao Y; Liu Y; Jin F; Meng Z
Yonsei Med J; 2021 Jul; 62(7):640-649. PubMed ID: 34164962
[TBL] [Abstract][Full Text] [Related]
6. miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting
Shan X; Zhang C; Li C; Fan X; Song G; Zhu J; Cao R; Zhang X; Zhu W
Cancer Pathog Ther; 2023 Apr; 1(2):87-97. PubMed ID: 38328402
[TBL] [Abstract][Full Text] [Related]
7. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway.
Cao M; Tian K; Sun W; Xu J; Tang Y; Wu S
Exp Ther Med; 2022 Jan; 23(1):97. PubMed ID: 34976139
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
[TBL] [Abstract][Full Text] [Related]
10. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma.
Garajei A; Parvin M; Mohammadi H; Allameh A; Hamidavi A; Sadeghi M; Emami A; Brand S
Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215154
[TBL] [Abstract][Full Text] [Related]
12. The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.
Xia Y; Hei N; Peng S; Cui Z
Head Neck; 2023 Sep; 45(9):2424-2437. PubMed ID: 37377048
[TBL] [Abstract][Full Text] [Related]
13. Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer.
Yu H; Luo S
Evid Based Complement Alternat Med; 2022; 2022():7807956. PubMed ID: 35815280
[TBL] [Abstract][Full Text] [Related]
14. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of long-chain noncoding RNA PCGEM1 in the regulation of the invasion and metastasis of oral squamous carcinoma cells via transforming growth factor β2/Smad2 signaling pathway].
Weng X; Li JS; Fan S
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Oct; 38(5):550-557. PubMed ID: 33085241
[TBL] [Abstract][Full Text] [Related]
16. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
Long Y; Li C; Zhu B
Bioengineered; 2022 May; 13(5):13055-13069. PubMed ID: 35635053
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression.
Huang C; Wang R; Lu J; He Y; Wu Y; Ma W; Xu J; Wu Z; Feng Z; Wu M
J Clin Lab Anal; 2022 Aug; 36(8):e24584. PubMed ID: 35792028
[TBL] [Abstract][Full Text] [Related]
18. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.
Song X; Jin Y; Yan M; Zhang Y; Chen B
Oncol Lett; 2019 Jan; 17(1):688-696. PubMed ID: 30655818
[TBL] [Abstract][Full Text] [Related]
20. Expression of microRNA-21 in saliva and tumor tissue of patients with oral squamous cell carcinoma: a predictor of cervical lymph node metastasis.
Jadhav KB; Shah V; Chauhan N; Shah N; Parmar G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):60-69. PubMed ID: 34518132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
